The Analysis of JOHNSON & JOHNSON's Holdings
Currently, JOHNSON & JOHNSON holds 17 types of securities in its portfolio with a total value $554.6M. In the most recent quarter, they have increased their positions in PTGX (+2.4M shares, valued at $213.9M), NBTX (+5.6M shares, valued at $130.0M), RAPP (+1.8M shares, valued at $54.1M); decreased their positions in CVRX (-78.6K shares, valued at $557.8K); initiated new positions in PTGX (+2.4M shares, valued at $213.9M), NBTX (+5.6M shares, valued at $130.0M), RAPP (+1.8M shares, valued at $54.1M). Stock Holdings
TickerCompany NameSharesShares âŗ%Event DateReport DateHistory
PTGX Protagonist Therapeutics Inc.2.4M sharesnew addition2025-12-312026-02-13
NBTX Nanobiotix S.A.5.6M sharesnew addition2025-12-312026-02-13 RAPP Rapport Therapeutics, Inc.1.8M sharesnew addition2025-12-312026-02-13 MGTX MeiraGTx Holdings plc6.6M sharesnew addition2025-12-312026-02-13 CVRX CVRx, Inc.4.0M shares-1.91%2025-12-312026-02-13 CTNM Contineum Therapeutics Inc.2.0M sharesnew addition2025-12-312026-02-13 LEGN Legend Biotech Corporation814.6K sharesnew addition2025-12-312026-02-13 XNCR Xencor, Inc.748.1K sharesnew addition2025-12-312026-02-13 PRCT Procept BioRobotics Corporation357.9K sharesnew addition2025-12-312026-02-13 FATE Fate Therapeutics, Inc.3.4M sharesnew addition2025-12-312026-02-13 NMRA Neumora Therapeutics, Inc.1.8M sharesnew addition2025-12-312026-02-13 RLYB Rallybio Corporation3.6M sharesnew addition2025-12-312026-02-13 LYEL Lyell Immunopharma, Inc.41.2K sharesnew addition2025-12-312026-02-13 VOR Vor Biopharma, Inc.53.7K sharesnew addition2025-12-312026-02-13 NNOX Nano-X Imaging Ltd.158.9K sharesnew addition2025-12-312026-02-13 LAB Standard BioTools, Inc.312.0K sharesnew addition2025-12-312026-02-13 Call Option Holdings
No call option holdings data available
Put Option Holdings
No put option holdings data available